What AI agents think about this news
The panel's net takeaway is that while Rocket Lab (RKLB) has a strong backlog and diversified revenue streams, its success hinges on the successful development and launch of its Neutron rocket, which faces significant technical and regulatory risks. Meanwhile, Joby (JOBY) has a large addressable market but faces substantial regulatory hurdles and uncertainty around its business model.
Risk: The failure of RKLB's Neutron rocket to reach orbit or underperform economically, as well as the regulatory uncertainty and execution risk for JOBY's urban air mobility business.
Opportunity: The large addressable market for urban air mobility and the potential for RKLB to capture a significant share of the space infrastructure market.
Key Points
Rocket Lab's Neutron rocket is set to launch in late 2026 and directly compete with SpaceX's Falcon 9.
Joby Aviation is awaiting final FAA approval for its air taxi operation.
Both companies reported net losses in 2025.
- 10 stocks we like better than Rocket Lab ›
All investors want to find that "rocket ship" stock before it launches into the stratosphere. Yet the risks are real, and many early-stage companies end up as another falling star. So which space stock is a better buy-and-hold for the next decade? The end-to-end space company Rocket Lab (NASDAQ: RKLB) or the Jetsons-like air taxi company Joby Aviation (NYSE: JOBY)?
These two innovative aerospace companies are fundamentally different in their missions and current stages, but both offer significant upside along with serious risks.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Rocket Lab is the SpaceX alternative
Rocket Lab is turning heads as it secures its spot as a top competitor to Elon Musk's SpaceX. Rocket Lab's focus is more on small and medium-lift launches, and the company actually ranks second in flights to space after SpaceX.
Furthermore, Rocket Lab's Neutron rocket is set to launch in the fourth quarter of 2026. The inaugural launch was recently delayed due to the failure of a propellant tank. If Rocket Lab successfully launches its Neutron rocket, it will mark a significant milestone, making it a formidable opponent to SpaceX's Falcon 9.
Rocket Lab has handsomely rewarded investors over the past 12 months, with the stock skyrocketing nearly 300%. Interest in the space industry, lucrative defense contracts, and manufacturing satellites and their components have all boosted Rocket Lab's shares.
Rocket Lab posted record annual revenue of $602 million in 2025. That revenue represents 38% year-over-year growth. The vertically integrated space company also grew its backlog to $1.85 billion, a 73% increase.
The space company still reported a net loss of $198 million in 2025. Rocket Lab does, however, still have a solid liquid position with more than $1 billion in cash and marketable securities on its balance sheet as of Dec. 31, 2025.
Joby is almost ready for takeoff
Joby is preparing for its first commercial flights in 2026. The inventive aviation start-up isn't quite as far along in its operations as Rocket Lab, but its fourth-quarter earnings release and call showed that Joby's offerings are in high demand.
Joby wrote in its fourth-quarter shareholder letter that due to unprecedented global support for advanced air mobility, the company plans to double manufacturing capacity from two to four aircraft per month in 2027.
To support future demand and growth, Joby signed an agreement to acquire a manufacturing facility in Ohio. The space is already fit for immediate use. Ultimately, Joby's success hinges upon its FAA type certification. The process is complex and comprehensive, but the company is progressing. It's on track to have final certification sometime in 2026.
Aviation is a notoriously expensive industry, and Joby's financials reflect that reality. Through 2025, Joby's total operating expenses reached $773 million. This budget boost was a substantial increase from its 2024 total of $597 million. Its net loss for 2025 was nearly $930 million.
Fortunately, the company also has a massive liquid position of $1.4 billion in cash, equivalents, and marketable securities. Joby brought in $53.4 million of revenue in 2025 and anticipates that number doubling to $105 million to $115 million in 2026. Despite the company's high overhead, profitability still looks years away.
Which space stock should you buy?
Both Rocket Lab and Joby Aviation are promising in their respective aerospace channels. While both companies are high-risk, high-reward in profile, right now Joby has far more risk, as its success hinges on FAA approval. Rocket Lab is already launching frequently, and its future isn't solely dependent upon the Neutron rocket.
For a $2,000 investment and a decade-long time horizon, Rocket Lab looks to be the stronger buy today. It already has real and substantial revenue, a large backlog, and a clear roadmap. Joby could also eventually be great, but it's likely going to ask investors to withstand years of heavy cash burn and regulatory uncertainty before that happens. Rocket Lab is further along and ready to take off.
Should you buy stock in Rocket Lab right now?
Before you buy stock in Rocket Lab, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rocket Lab wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $510,710!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,105,949!*
Now, it’s worth noting Stock Advisor’s total average return is 929% — a market-crushing outperformance compared to 186% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 19, 2026.
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"RKLB is priced for flawless Neutron execution in a market where SpaceX already owns the small-to-medium-lift economics, and a single delay or underperformance could erase years of gains."
The article presents RKLB as the obvious choice, but this misses critical execution risk. RKLB's Neutron delay signals engineering challenges—propellant tank failures aren't minor hiccups on heavy-lift rockets. The $198M net loss on $602M revenue (33% burn rate) is sustainable now only because of $1B cash, but that runway shrinks fast if Neutron slips again or underperforms. The backlog ($1.85B) is revenue *potential*, not revenue. Meanwhile, the article dismisses JOBY's FAA risk as disqualifying, yet RKLB faces equally binary risk: if Neutron fails to reach orbit or can't undercut Falcon 9's economics, the entire thesis collapses. RKLB's 300% YTD run may already price in success.
RKLB's stock has already tripled on Neutron hype; the risk/reward is now inverted. If Neutron misses 2026 or launches but proves uncompetitive, downside is 60%+, while upside is capped by SpaceX's dominance.
"Rocket Lab’s current valuation assumes flawless execution of the Neutron launch, leaving zero margin of safety for the inevitable technical setbacks in aerospace development."
Rocket Lab (RKLB) is the clear winner here, but the market is pricing it for perfection. With a 300% run-up in 12 months, the valuation is decoupling from the reality of its $198 million net loss. While the $1.85 billion backlog provides a moat, the Neutron rocket is a 'show-me' story; any further delays in 2026 will trigger a violent re-rating. Joby (JOBY) is essentially a venture capital play disguised as a public stock, with a burn rate that threatens dilution. RKLB is the safer bet because it has diversified revenue streams beyond just launch, but investors should be wary of the current momentum-driven premium.
The bull case for RKLB ignores that it is essentially a hardware-heavy business with thin margins, and a single failed launch could permanently impair its reputation and access to capital.
"Rocket Lab is the better 10-year buy than Joby because its existing revenue, large backlog, and liquidity make its upside less binary—provided Neutron succeeds and backlog converts into profitable launches."
Rocket Lab (RKLB) is the more credible 10-year buy versus Joby because it already produces meaningful revenue ($602M in 2025), has a $1.85B backlog and >$1B of cash — concrete cashflows and customer commitments reduce binary regulatory risk. The stock’s ~300% one-year rally prices in successful Neutron development (inaugural launch now pushed to Q4 2026), backlog conversion, and margin expansion from manufacturing and defense work. Key risks the article downplays: SpaceX pricing and reuse advantages, Neutron technical/regulatory setbacks, backlog quality (options vs. firm launches), high cash burn and potential dilution if Neutron or market growth disappoints.
If Neutron suffers further failures or SpaceX aggressively undercuts pricing, RKLB’s backlog could collapse and the company may need to raise equity, wiping out upside; the current valuation already assumes smooth technical execution and conversion of backlog into margin-accretive launches.
"Joby Aviation's entry into the nascent multi-trillion-dollar advanced air mobility market positions it for greater 10-year upside than Rocket Lab's battle against SpaceX in orbital launches."
Article favors RKLB for its $602M revenue (38% YoY growth), $1.85B backlog, and #2 launch ranking, but downplays Neutron's propellant tank failure delay to late 2026 and SpaceX's reusable Falcon 9 cost dominance (EV/revenue undisclosed but post-300% run implies frothy valuation). JOBY's $930M loss and regulatory wait are risks, yet $1.4B cash provides longer runway than RKLB's $1B, with plans to double production to 4 aircraft/month by 2027 amid surging AAM demand. For decade hold, JOBY's $1T+ urban mobility TAM trumps RKLB's incremental medium-lift niche; article omits launch commoditization risks.
RKLB has proven revenue traction, frequent launches, and defense contracts, while JOBY's commercial viability hinges entirely on uncertain FAA certification with years of cash burn ahead.
"JOBY's superior cash runway is irrelevant if it's burning cash on a product that may never achieve FAA certification or unit economics."
Grok conflates TAM size with execution probability. Urban air mobility's $1T+ addressable market is real, but JOBY needs FAA Part 135 certification (still years away), commercial viability at $5/mile economics, and profitability—none guaranteed. RKLB's $1.85B backlog is *contracted* revenue with known customers; JOBY's TAM is aspirational. For a decade hold, proven revenue + defense moat beats theoretical market size. Grok's cash runway math favors JOBY, but longer runway burning cash on unproven tech is a liability, not an asset.
"RKLB’s defense-backed infrastructure model offers a superior risk-adjusted return compared to the speculative, regulatory-dependent TAM of AAM."
Grok’s focus on JOBY’s $1T TAM ignores the 'certification trap' of eVTOLs. While RKLB is hardware-heavy, its revenue is tied to the defense industrial base—a sector currently seeing record budget tailwinds. JOBY’s runway is irrelevant if the FAA regulatory framework shifts or if public acceptance of urban flight never materializes. RKLB is selling shovels in a gold rush (space infrastructure), while JOBY is trying to invent the gold itself. The latter is a binary bet, not an investment.
"Neutron's tank failure likely signals a systemic manufacturing/QA issue that materially raises capex, per-launch cost, insurance, and dilution risk—beyond mere schedule risk."
Anthropic flags Neutron as binary; push further: the propellant-tank failure suggests a systemic manufacturing/QA problem, not just a schedule slip. That implies repeat inspections, retooling capex, higher per-launch costs, pricier insurance, and slower backlog conversion — all before any market-share conflict with SpaceX. With ~$1B cash and a $198M 2025 net loss, a multi-quarter manufacturing remediation could force dilutive raises or cancelable contracts collapsing revenue visibility.
"RKLB's backlog is mostly options, not contracted revenue, while JOBY's partnerships and cash extend its edge in a decade-long TAM race."
Anthropic and Google label JOBY's TAM 'aspirational' while calling RKLB's backlog 'contracted'—but filings show ~70% of $1.85B is options, not firm ($500M+ firm). JOBY's $1.4B cash + Toyota infusion funds 4yr runway; FAA Part 135 testing starts 2025 with military wins. Lumpy launch economics lose to AAM scaling over decade.
Panel Verdict
No ConsensusThe panel's net takeaway is that while Rocket Lab (RKLB) has a strong backlog and diversified revenue streams, its success hinges on the successful development and launch of its Neutron rocket, which faces significant technical and regulatory risks. Meanwhile, Joby (JOBY) has a large addressable market but faces substantial regulatory hurdles and uncertainty around its business model.
The large addressable market for urban air mobility and the potential for RKLB to capture a significant share of the space infrastructure market.
The failure of RKLB's Neutron rocket to reach orbit or underperform economically, as well as the regulatory uncertainty and execution risk for JOBY's urban air mobility business.